Ghent University Academic Bibliography

Advanced

Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD

David Price, Barbara Yawn, Guy Brusselle UGent and Andrea Rossi (2013) PRIMARY CARE RESPIRATORY JOURNAL. 22(1). p.92-100
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (review)
publication status
published
subject
keyword
OBSTRUCTIVE PULMONARY-DISEASE, safety, inhaled corticosteroids, efficacy, chronic obstructive pulmonary disease, RANDOMIZED CONTROLLED-TRIAL, LUNG-VOLUME REDUCTION, QUALITY-OF-LIFE, FLUTICASONE PROPIONATE, PRIMARY-CARE, SALMETEROL/FLUTICASONE PROPIONATE, THERAPY GUIDELINES, EXACERBATIONS, PNEUMONIA
journal title
PRIMARY CARE RESPIRATORY JOURNAL
Prim. Care Respir. J.
volume
22
issue
1
pages
92 - 100
Web of Science type
Review
Web of Science id
000316094700022
JCR category
PRIMARY HEALTH CARE
JCR impact factor
2.909 (2013)
JCR rank
2/18 (2013)
JCR quartile
1 (2013)
ISSN
1471-4418
DOI
10.4104/pcrj.2012.00092
language
English
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
3067231
handle
http://hdl.handle.net/1854/LU-3067231
date created
2012-12-07 09:48:15
date last changed
2014-01-14 10:59:46
@article{3067231,
  author       = {Price, David and Yawn, Barbara and Brusselle, Guy and Rossi, Andrea},
  issn         = {1471-4418},
  journal      = {PRIMARY CARE RESPIRATORY JOURNAL},
  keyword      = {OBSTRUCTIVE PULMONARY-DISEASE,safety,inhaled corticosteroids,efficacy,chronic obstructive pulmonary disease,RANDOMIZED CONTROLLED-TRIAL,LUNG-VOLUME REDUCTION,QUALITY-OF-LIFE,FLUTICASONE PROPIONATE,PRIMARY-CARE,SALMETEROL/FLUTICASONE PROPIONATE,THERAPY GUIDELINES,EXACERBATIONS,PNEUMONIA},
  language     = {eng},
  number       = {1},
  pages        = {92--100},
  title        = {Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD},
  url          = {http://dx.doi.org/10.4104/pcrj.2012.00092},
  volume       = {22},
  year         = {2013},
}

Chicago
Price, David, Barbara Yawn, Guy Brusselle, and Andrea Rossi. 2013. “Risk-to-benefit Ratio of Inhaled Corticosteroids in Patients with COPD.” Primary Care Respiratory Journal 22 (1): 92–100.
APA
Price, David, Yawn, B., Brusselle, G., & Rossi, A. (2013). Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD. PRIMARY CARE RESPIRATORY JOURNAL, 22(1), 92–100.
Vancouver
1.
Price D, Yawn B, Brusselle G, Rossi A. Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD. PRIMARY CARE RESPIRATORY JOURNAL. 2013;22(1):92–100.
MLA
Price, David, Barbara Yawn, Guy Brusselle, et al. “Risk-to-benefit Ratio of Inhaled Corticosteroids in Patients with COPD.” PRIMARY CARE RESPIRATORY JOURNAL 22.1 (2013): 92–100. Print.